Cuba rejected on Tuesday recent statements made by Luis Almagro, secretary-general of the Organization of America States (OAS), on the island's democratic system, saying he had no "credibility" to speak about Cuba.
Speaking to local media, Rogelio Sierra, Cuba's deputy foreign minister, stated Almagro's remarks about Cuba were made in Miami city in U.S. Florida state where he met with a group of people who "defend, support and encourage aggressive actions" against Cuba, including terrorism and the U.S. economic blockade.
"Almagro has no credibility, moral or ethics, to judge what the Cuban government and its people do. He makes a big mistake in ignoring our decision to be sovereign and independent," said Sierra.
The OAS official visited Miami last Saturday to visit a Cuban dissident group. He used the occasion to call for "democratic reforms" and demanded that Havana hold Western-style elections to choose its next leader as actual president, Raul Castro, will step down in April.
Havana's deputy foreign minister pointed out that Almagro tried to delegitimize Cuba's sovereignty and independence to decide its political system while supporting "illegal opposition groups and their allies in the U.S."
"He met in Miami with a sector of the Cuban community in the United States, which still dreams of overthrowing the Revolution. On the contrary, he has not said a word about recent remarks made by the U.S. Secretary of State, Rex Tillerson, who supported a military coup against Venezuela," said Sierra.
Despite being a founding member of the OAS, Cuba was suspended in 1962. In June 2009, foreign ministers of OAS member countries lifted Cuba's suspension.
Havana, however, has reiterated it would not return to the OAS.
- US Criticisms Are an Attack on Mutual Trust, China Says
- Cuban Mission at UN Warns over US Blockade's Damage on Culture
- Cuban President Extendes Talks with U.S. Businesspeople
- State Agriculture Officials Underscore Commitment to Enhanced Trading Relationship with President of Cuba
- Cuba and US to establish first joint venture in field of biotechnology